The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection
Open accessAbstract
A sudden outbreak of COVID-19 caused by a novel coronavirus, SARS-CoV-2, in Wuhan, China in December 2019 quickly grew into a global pandemic, putting at risk not only the global healthcare system, but also the world economy. As the disease continues to spread rapidly, the development of prophylactic and therapeutic approaches is urgently required. Although some progress has been made in understanding the viral structure and invasion mechanism of coronaviruses that may cause severe cases of the syndrome, due to the limited understanding of the immune effects caused by SARS-CoV-2, it is difficult for us to prevent patients from developing acute respiratory distress syndrome (ARDS) and pulmonary fibrosis (PF), the major complications of coronavirus infection. Therefore, any potential treatments should focus not only on direct killing of coronaviruses and prevention strategies by vaccine development, but also on keeping in check the acute immune/inflammatory responses, resulting in ARDS and PF. In addition, potential treatments currently under clinical trials focusing on killing coronaviruses or on developing vaccines preventing coronavirus infection largely ignore the host immune response. However, taking care of SARS-CoV-2 infected patients with ARDS and PF is considered to be the major difficulty. Therefore, further understanding of the host immune response to SARS-CoV-2 is extremely important for clinical resolution and saving medication cost. In addition to a breif overview of the structure, infection mechanism, and possible therapeutic approaches, we summarized and compared the hematopathologic effect and immune responses to SARS-CoV, MERS-CoV, and SARS-CoV-2. We also discussed the indirect immune response caused by SARS and direct infection, replication, and destroying of immune cells by MERS-CoV. The molecular mechanisms of SARS-CoV and MERS-CoV infection-induced lymphopenia or cytokine storm may provide some hint toward fight against SARS-CoV-2, the novel coronavirus. This may provide guidance over using immune therapy as a combined treatment to prevent patients developing severe respiratory syndrome and largely reduce complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Withdrawn: Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy
Liu, Y., Chen, H., Tang, K., & Guo, Y. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.02.028 · Cited by 481
RetractedWang, X., Xu, W., Hu, G., Xia, S., Sun, Z., Liu, Z., Xie, Y., Zhang, R., Jiang, S., & Lu, L. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0498-4 · Cited by 175
RetractedWang, X., Xu, W., Hu, G., Xia, S., Sun, Z., Liu, Z., Xie, Y., Zhang, R., Jiang, S., & Lu, L. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0424-9 · Cited by 161
RetractedClinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Self-citationHoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066
COVID-19: consider cytokine storm syndromes and immunosuppression
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020) · Science · doi:10.1126/science.abb2507 · Cited by 8,897
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Lan, J., Ge, J., Yu, J., Shan, S., Zhou, H., Fan, S., Zhang, Q., Shi, X., Wang, Q., Zhang, L., et al. (2020) · Nature · doi:10.1038/s41586-020-2180-5 · Cited by 5,983
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923
Hamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
Yan, R., Zhang, Y., Li, Y., Xia, L., Guo, Y., & Zhou, Q. (2020) · Science · doi:10.1126/science.abb2762 · Cited by 5,040
Coronaviruses: An Overview of Their Replication and Pathogenesis
Fehr, A. R., & Perlman, S. (2015) · Methods in Molecular Biology · doi:10.1007/978-1-4939-2438-7_1 · Cited by 3,787
COVID-19 infection: Emergence, transmission, and characteristics of human coronaviruses
Shereen, M. A., Khan, S., Kazmi, A., Bashir, N., & Siddique, R. (2020) · Journal of Advanced Research · doi:10.1016/j.jare.2020.03.005 · Cited by 3,536
SARS and MERS: recent insights into emerging coronaviruses
de Wit, E., van Doremalen, N., Falzarano, D., & Munster, V. J. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.81 · Cited by 3,510
To, K. K.-W., Tsang, O. T.-Y., Leung, W.-S., Tam, A. R., Wu, T.-C., Lung, D. C., Yip, C. C.-Y., Cai, J.-P., Chan, J. M.-C., Chik, T. S.-H., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30196-1 · Cited by 3,066
Emerging coronaviruses: Genome structure, replication, and pathogenesis
Chen, Y., Liu, Q., & Guo, D. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25681 · Cited by 3,062
Self-citationChan, J. F.-W., Kok, K.-H., Zhu, Z., Chu, H., To, K. K.-W., Yuan, S., & Yuen, K.-Y. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1719902 · Cited by 3,059
Structure, Function, and Evolution of Coronavirus Spike Proteins
Li, F. (2016) · Annual Review of Virology · doi:10.1146/annurev-virology-110615-042301 · Cited by 2,740
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019
Zhao, J., Yuan, Q., Wang, H., Liu, W., Liao, X., Su, Y., Wang, X., Yuan, J., Li, T., Li, J., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa344 · Cited by 2,607
Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.5.e1 · Cited by 2,485
Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
Rota, P. A., Oberste, M. S., Monroe, S. S., Nix, W. A., Campagnoli, R., Icenogle, J. P., Peñaranda, S., Bankamp, B., Maher, K., Chen, M.-H., et al. (2003) · Science · doi:10.1126/science.1085952 · Cited by 2,474
Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China
Wu, A., Peng, Y., Huang, B., Ding, X., Wang, X., Niu, P., Meng, J., Zhu, Z., Zhang, Z., Wang, J., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.02.001 · Cited by 2,361
Coronavirus envelope protein: current knowledge
Schoeman, D., & Fielding, B. C. (2019) · Virology Journal · doi:10.1186/s12985-019-1182-0 · Cited by 2,074
Functional exhaustion of antiviral lymphocytes in COVID-19 patients
Zheng, M., Gao, Y., Wang, G., Song, G., Liu, S., Sun, D., Xu, Y., & Tian, Z. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0402-2 · Cited by 1,768 · cited 1×
“As for adaptive immunity, it is known that the low levels of CD4+ and CD8+ T cells are related to the mortality of SARSCoV-2 patients (104, 105).”
BackgroundThe spike protein of SARS-CoV — a target for vaccine and therapeutic development
Du, L., He, Y., Zhou, Y., Liu, S., Zheng, B.-J., & Jiang, S. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2090 · Cited by 1,661
Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic
(2020) · Asian Pacific Journal of Allergy and Immunology · doi:10.12932/ap-200220-0772 · Cited by 1,537 · cited 1×
“After recognition, the downstream signaling cascade results in activation of NFκB and IRF3 transcriptional activity (62).”
BackgroundChannappanavar, R., Fehr, A. R., Vijay, R., Mack, M., Zhao, J., Meyerholz, D. K., & Perlman, S. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.01.007 · Cited by 1,419
Multiple organ infection and the pathogenesis of SARS
Gu, J., Gong, E., Zhang, B., Zheng, J., Gao, Z., Zhong, Y., Zou, W., Zhan, J., Wang, S., Xie, Z., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050828 · Cited by 1,379
Mechanisms of Coronavirus Cell Entry Mediated by the Viral Spike Protein
Belouzard, S., Millet, J. K., Licitra, B. N., & Whittaker, G. R. (2012) · Viruses · doi:10.3390/v4061011 · Cited by 1,368
Xiong, Y., Liu, Y., Cao, L., Wang, D., Guo, M., Jiang, A., Guo, D., Hu, W., Yang, J., Tang, Z., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1747363 · Cited by 1,076 · cited 1×
“The up-regulation of apoptosis and autophagy in PBMC of SARS-CoV-2 patients (106) suggested that, similar to how MERS can directly infect T cells and induce apoptosis (47), SARS-CoV-2 may cause lymphocytopenia through inducing T-cell apoptosis or autophagic cell death.”
Self-citationThe Coronavirus Nucleocapsid Is a Multifunctional Protein
McBride, R., Van Zyl, M., & Fielding, B. (2014) · Viruses · doi:10.3390/v6082991 · Cited by 942
Single-Cell RNA Expression Profiling of ACE2, the Receptor of SARS-CoV-2
Zhao, Y., Zhao, Z., Wang, Y., Zhou, Y., Ma, Y., & Zuo, W. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202001-0179le · Cited by 916
Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection
Diao, B., Wang, C., Wang, R., Feng, Z., Zhang, J., Yang, H., Tan, Y., Wang, H., Wang, C., Liu, L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22781-1 · Cited by 900
Self-citationSingle-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2
Zhao, Y., Zhao, Z., Wang, Y., Zhou, Y., Ma, Y., & Zuo, W. (2020) · doi:10.1101/2020.01.26.919985 · Cited by 860
A structural analysis of M protein in coronavirus assembly and morphology
Neuman, B. W., Kiss, G., Kunding, A. H., Bhella, D., Baksh, M. F., Connelly, S., Droese, B., Klaus, J. P., Makino, S., Sawicki, S. G., et al. (2011) · Journal of Structural Biology · doi:10.1016/j.jsb.2010.11.021 · Cited by 841
Chu, H., Chan, J. F.-W., Wang, Y., Yuen, T. T.-T., Chai, Y., Hou, Y., Shuai, H., Yang, D., Hu, B., Huang, X., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa410 · Cited by 667
Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry
Wan, Y., Shang, J., Sun, S., Tai, W., Chen, J., Geng, Q., He, L., Chen, Y., Wu, J., Shi, Z., et al. (2020) · Journal of Virology · doi:10.1128/jvi.02015-19 · Cited by 662
Self-citationChan, J. F.-W., Yao, Y., Yeung, M.-L., Deng, W., Bao, L., Jia, L., Li, F., Xiao, C., Gao, H., Yu, P., et al. (2015) · Journal of Infectious Diseases · doi:10.1093/infdis/jiv392 · Cited by 608
Nieto-Torres, J. L., DeDiego, M. L., Verdiá-Báguena, C., Jimenez-Guardeño, J. M., Regla-Nava, J. A., Fernandez-Delgado, R., Castaño-Rodriguez, C., Alcaraz, A., Torres, J., Aguilella, V. M., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004077 · Cited by 559
Pan, X.-W., Xu, D., Zhang, H., Zhou, W., Wang, L.-H., & Cui, X.-G. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06026-1 · Cited by 555
Simmons, G., Reeves, J. D., Rennekamp, A. J., Amberg, S. M., Piefer, A. J., & Bates, P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306446101 · Cited by 543
Frieman, M., Yount, B., Heise, M., Kopecky-Bromberg, S. A., Palese, P., & Baric, R. S. (2007) · Journal of Virology · doi:10.1128/jvi.01012-07 · Cited by 507
Human Coronavirus 229E Remains Infectious on Common Touch Surface Materials
Warnes, S. L., Little, Z. R., & Keevil, C. W. (2015) · mBio · doi:10.1128/mbio.01697-15 · Cited by 506
Kuba, K., Imai, Y., Ohto-Nakanishi, T., & Penninger, J. M. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.06.003 · Cited by 480
Chemokine up-regulation in SARS-coronavirus–infected, monocyte-derived human dendritic cells
Law, H. K. W., Cheung, C. Y., Ng, H. Y., Sia, S. F., Chan, Y. O., Luk, W., Nicholls, J. M., Peiris, J. S. M., & Lau, Y. L. (2005) · Blood · doi:10.1182/blood-2004-10-4166 · Cited by 471
Totura, A. L., Whitmore, A., Agnihothram, S., Schäfer, A., Katze, M. G., Heise, M. T., & Baric, R. S. (2015) · mBio · doi:10.1128/mbio.00638-15 · Cited by 455
Rapid generation of a mouse model for Middle East respiratory syndrome
Zhao, J., Li, K., Wohlford-Lenane, C., Agnihothram, S. S., Fett, C., Zhao, J., Gale, M. J., Baric, R. S., Enjuanes, L., Gallagher, T., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323279111 · Cited by 452
Chu, H., Zhou, J., Wong, B. H.-Y., Li, C., Chan, J. F.-W., Cheng, Z.-S., Yang, D., Wang, D., Lee, A. C.-Y., Li, C., et al. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiv380 · Cited by 448
DeDiego, M. L., Álvarez, E., Almazán, F., Rejas, M. T., Lamirande, E., Roberts, A., Shieh, W.-J., Zaki, S. R., Subbarao, K., & Enjuanes, L. (2007) · Journal of Virology · doi:10.1128/jvi.01467-06 · Cited by 438
Ruan, Y., Wei, C. L., Ling, A. E., Vega, V. B., Thoreau, H., Se Thoe, S. Y., Chia, J.-M., Ng, P., Chiu, K. P., Lim, L., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13414-9 · Cited by 437
Is COVID-19 receiving ADE from other coronaviruses?
Tetro, J. A. (2020) · Microbes and Infection · doi:10.1016/j.micinf.2020.02.006 · Cited by 434
RNA Replication of Mouse Hepatitis Virus Takes Place at Double-Membrane Vesicles
Gosert, R., Kanjanahaluethai, A., Egger, D., Bienz, K., & Baker, S. C. (2002) · Journal of Virology · doi:10.1128/jvi.76.8.3697-3708.2002 · Cited by 432
Zhou, J., Chu, H., Li, C., Wong, B. H.-Y., Cheng, Z.-S., Poon, V. K.-M., Sun, T., Lau, C. C.-Y., Wong, K. K.-Y., Chan, J. Y.-W., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit504 · Cited by 428
Narayanan, K., Huang, C., Lokugamage, K., Kamitani, W., Ikegami, T., Tseng, C.-T. K., & Makino, S. (2008) · Journal of Virology · doi:10.1128/jvi.02472-07 · Cited by 427
Duration of Antibody Responses after Severe Acute Respiratory Syndrome
Wu, L.-P., Wang, N.-C., Chang, Y.-H., Tian, X.-Y., Na, D.-Y., Zhang, L.-Y., Zheng, L., Lan, T., Wang, L.-F., & Liang, G.-D. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1310.070576 · Cited by 426 · cited 1×
“In addition to the humoral response, a 3-year follow-up study of 176 SARS patients showed that the level of IgM peaked at ∼1 month after symptoms onset, and IgG peaked at 2–4months (90).”
BackgroundLack of Reinfection in Rhesus Macaques Infected with SARS-CoV-2
Bao, L., Deng, W., Gao, H., Xiao, C., Liu, J., Xue, J., Lv, Q., Liu, J., Yu, P., Xu, Y., et al. (2020) · doi:10.1101/2020.03.13.990226 · Cited by 419
SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon
Totura, A. L., & Baric, R. S. (2012) · Current Opinion in Virology · doi:10.1016/j.coviro.2012.04.004 · Cited by 415
Ultrastructural Characterization of SARS Coronavirus
Goldsmith, C. S., Tatti, K. M., Ksiazek, T. G., Rollin, P. E., Comer, J. A., Lee, W. W., Rota, P. A., Bankamp, B., Bellini, W. J., & Zaki, S. R. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1002.030913 · Cited by 405
Chen, J., Lau, Y. F., Lamirande, E. W., Paddock, C. D., Bartlett, J. H., Zaki, S. R., & Subbarao, K. (2010) · Journal of Virology · doi:10.1128/jvi.01281-09 · Cited by 399
T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV
Liu, W. J., Zhao, M., Liu, K., Xu, K., Wong, G., Tan, W., & Gao, G. F. (2017) · Antiviral Research · doi:10.1016/j.antiviral.2016.11.006 · Cited by 395
Transmission of MERS-Coronavirus in Household Contacts
Drosten, C., Meyer, B., Müller, M. A., Corman, V. M., Al-Masri, M., Hossain, R., Madani, H., Sieberg, A., Bosch, B. J., Lattwein, E., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1405858 · Cited by 393
Buchholz, U. J., Bukreyev, A., Yang, L., Lamirande, E. W., Murphy, B. R., Subbarao, K., & Collins, P. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403492101 · Cited by 385
Feng, Z., Diao, B., Wang, R., Wang, G., Wang, C., Tan, Y., Liu, L., Wang, C., Liu, Y., Liu, Y., et al. (2020) · medRxiv · doi:10.1101/2020.03.27.20045427 · Cited by 362
Self-citationIsolation of coronavirus envelope glycoproteins and interaction with the viral nucleocapsid
Sturman, L. S., Holmes, K. V., & Behnke, J. (1980) · Journal of Virology · doi:10.1128/jvi.33.1.449-462.1980 · Cited by 348
Zhao, J., Zhao, J., & Perlman, S. (2010) · Journal of Virology · doi:10.1128/jvi.01049-10 · Cited by 340
Architecture of the SARS coronavirus prefusion spike
Beniac, D. R., Andonov, A., Grudeski, E., & Booth, T. F. (2006) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1123 · Cited by 334
Molecular pathology of emerging coronavirus infections
Gralinski, L. E., & Baric, R. S. (2015) · The Journal of Pathology · doi:10.1002/path.4454 · Cited by 319
Jaume, M., Yip, M. S., Cheung, C. Y., Leung, H. L., Li, P. H., Kien, F., Dutry, I., Callendret, B., Escriou, N., Altmeyer, R., et al. (2011) · Journal of Virology · doi:10.1128/jvi.00671-11 · Cited by 314
Antibody-Dependent Enhancement of Virus Infection and Disease
Tirado, S. M. C., & Yoon, K.-J. (2003) · Viral Immunology · doi:10.1089/088282403763635465 · Cited by 313
Al-Abdallat, M. M., Payne, D. C., Alqasrawi, S., Rha, B., Tohme, R. A., Abedi, G. R., Al Nsour, M., Iblan, I., Jarour, N., Farag, N. H., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu359 · Cited by 308
Yoshikawa, T., Hill, T., Li, K., Peters, C. J., & Tseng, C.-T. K. (2009) · Journal of Virology · doi:10.1128/jvi.01792-08 · Cited by 293
Interaction of SARS and MERS Coronaviruses with the Antiviral Interferon Response
Kindler, E., Thiel, V., & Weber, F. (2016) · Advances in Virus Research · doi:10.1016/bs.aivir.2016.08.006 · Cited by 290
Li, T., Qiu, Z., Zhang, L., Han, Y., He, W., Liu, Z., Ma, X., Fan, H., Lu, W., Xie, J., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/381535 · Cited by 282
Nal, B., Chan, C., Kien, F., Siu, L., Tse, J., Chu, K., Kam, J., Staropoli, I., Crescenzo-Chaigne, B., Escriou, N., et al. (2005) · Journal of General Virology · doi:10.1099/vir.0.80671-0 · Cited by 272
Zhao, J., Zhao, J., Legge, K., & Perlman, S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci59777 · Cited by 265
Leung, D. T. M., Tam, F. C. H., Ma, C. H., Chan, P. K. S., Cheung, J. L. K., Niu, H., Tam, J. S. L., & Lim, P. L. (2004) · The Journal of Infectious Diseases · doi:10.1086/422040 · Cited by 212
Zhuang, M., Cheng, Y., Zhang, J., Jiang, X., Wang, L., Deng, J., & Wang, P. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26139 · Cited by 208
MyD88 Is Required for Protection from Lethal Infection with a Mouse-Adapted SARS-CoV
Sheahan, T., Morrison, T. E., Funkhouser, W., Uematsu, S., Akira, S., Baric, R. S., & Heise, M. T. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000240 · Cited by 207
Type 1 Interferons and Antiviral CD8 T-Cell Responses
Welsh, R. M., Bahl, K., Marshall, H. D., & Urban, S. L. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002352 · Cited by 189
Cui, L., Wang, H., Ji, Y., Yang, J., Xu, S., Huang, X., Wang, Z., Qin, L., Tien, P., Zhou, X., et al. (2015) · Journal of Virology · doi:10.1128/jvi.01331-15 · Cited by 188
Self-citationA Conserved Domain in the Coronavirus Membrane Protein Tail Is Important for Virus Assembly
Arndt, A. L., Larson, B. J., & Hogue, B. G. (2010) · Journal of Virology · doi:10.1128/jvi.01131-10 · Cited by 187
Li, W., Sui, J., Huang, I.-C., Kuhn, J. H., Radoshitzky, S. R., Marasco, W. A., Choe, H., & Farzan, M. (2007) · Virology · doi:10.1016/j.virol.2007.04.035 · Cited by 185
TGEV corona virus ORF4 encodes a membrane protein that is incorporated into virions
Godet, M., L'Haridon, R., Vautherot, J.-F., & Laude, H. (1992) · Virology · doi:10.1016/0042-6822(92)90521-p · Cited by 185
Mosaic Structure of Human Coronavirus NL63, One Thousand Years of Evolution
Pyrc, K., Dijkman, R., Deng, L., Jebbink, M. F., Ross, H. A., Berkhout, B., & van der Hoek, L. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.09.074 · Cited by 183
Chu, H., Zhou, J., Ho-Yin Wong, B., Li, C., Cheng, Z.-S., Lin, X., Kwok-Man Poon, V., Sun, T., Choi-Yi Lau, C., Fuk-Woo Chan, J., et al. (2014) · Virology · doi:10.1016/j.virol.2014.02.018 · Cited by 179
Hurst, K. R., Koetzner, C. A., & Masters, P. S. (2013) · Journal of Virology · doi:10.1128/jvi.01275-13 · Cited by 167
Identification of In Vivo-Interacting Domains of the Murine Coronavirus Nucleocapsid Protein
Hurst, K. R., Koetzner, C. A., & Masters, P. S. (2009) · Journal of Virology · doi:10.1128/jvi.00440-09 · Cited by 166
Yang, Y., Xiong, Z., Zhang, S., Yan, Y., Nguyen, J., Ng, B., Lu, H., Brendese, J., Yang, F., Wang, H., et al. (2005) · Biochemical Journal · doi:10.1042/bj20050698 · Cited by 162
Self-citationFan, H., Ooi, A., Tan, Y. W., Wang, S., Fang, S., Liu, D. X., & Lescar, J. (2005) · Structure · doi:10.1016/j.str.2005.08.021 · Cited by 160
Severe Acute Respiratory Syndrome (SARS)
Cleri, D. J., Ricketti, A. J., & Vernaleo, J. R. (2010) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2009.10.005 · Cited by 159
Peng, H., Yang, L., Wang, L., Li, J., Huang, J., Lu, K., Koup, R. A., Bailer, R. T., & Wu, C. Y. (2006) · Virology · doi:10.1016/j.virol.2006.03.036 · Cited by 155
Understanding the T cell immune response in SARS coronavirus infection
Oh, H. J., Gan, S. K., Bertoletti, A., & Tan, Y. (2012) · Emerging Microbes & Infections · doi:10.1038/emi.2012.26 · Cited by 155
Zhao, J., Zhao, J., van Rooijen, N., & Perlman, S. M. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000636 · Cited by 154
Neutralizing Antibody Response and SARS Severity
Ho, M., Chen, W., Chen, H., Lin, S.-F., Wang, M.-C., Di, J., Lu, Y., Liu, C., Chang, S., Chao, C.-L., et al. (2005) · Emerging infectious diseases · doi:10.3201/eid1111.040659 · Cited by 144
Self-citationKlausegger, A., Strobl, B., Regl, G., Kaser-Eichberger, A., Luytjes, W., & Vlasak, R. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.3737-3743.1999 · Cited by 133
Cai, Y., Hao, Z., Gao, Y., Wei, P., Wang, Q., Peng, S., Zhao, B., Sun, W., Zhu, M., Li, K., et al. (2020) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2020.04.003 · Cited by 115
Wang, Y., Sin, W.-Y. F., Xu, G., Yang, H.-H., Wong, T.-Y., Pang, X., He, X., Zhang, H., Ng, J. N. L., Cheng, C.-S. S., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.5612-5618.2004 · Cited by 109
Molecular mechanisms of severe acute respiratory syndrome (SARS)
Groneberg, D. A., Hilgenfeld, R., & Zabel, P. (2005) · Respiratory Research · doi:10.1186/1465-9921-6-8 · Cited by 107
Hemagglutinin-esterase, a novel structural protein of torovirus
Cornelissen, L. A., Wierda, C. M. H., van der Meer, F. J. U. M., Herrewegh, A. A. P. M., Horzinek, M. C., Egberink, H. F., & de Groot, R. J. (1997) · Journal of Virology · doi:10.1128/jvi.71.7.5277-5286.1997 · Cited by 105
Skariyachan, S., Challapilli, S. B., Packirisamy, S., Kumargowda, S. T., & Sridhar, V. S. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00569 · Cited by 102
Tynell, J., Westenius, V., Rönkkö, E., Munster, V. J., Melén, K., Österlund, P., & Julkunen, I. (2015) · Journal of General Virology · doi:10.1099/jgv.0.000351 · Cited by 92
Subcellular localization of the severe acute respiratory syndrome coronavirus nucleocapsid protein
You, J., Dove, B. K., Enjuanes, L., et al. (2005) · Journal of General Virology · doi:10.1099/vir.0.81076-0 · Cited by 90
Al-Qahtani, A. A., Lyroni, K., Aznaourova, M., Tseliou, M., Al‐Anazi, M. R., Al‐Ahdal, M. N., Alkahtani, S. H., Sourvinos, G., & Tsatsanis, C. (2017) · Oncotarget · doi:10.18632/oncotarget.14754 · Cited by 80
Middle East Respiratory Syndrome Coronavirus “MERS-CoV”: Current Knowledge Gaps
Banik, G. R., Khandaker, G., & Rashid, H. (2015) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2015.04.002 · Cited by 75
Lu, L., Manopo, I., Leung, B. P. L., Chng, H. H., Ling, A. E., Chee, L. L., Ooi, E. E., Chan, S.-W., & Kwang, J. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.4.1570-1576.2004 · Cited by 69
Xiong, Y., Liu, Y., Cao, L., Wang, D., Guo, M. S., Guo, D., Hu, W., Yang, J., Tang, Z., Zhang, Q., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3549993 · Cited by 66
Self-citationMiddle East respiratory syndrome coronavirus (MERS-CoV): evidence and speculations
Abdel-Moneim, A. S. (2014) · Archives of Virology · doi:10.1007/s00705-014-1995-5 · Cited by 62
Viral Architecture of SARS-CoV-2 with Post-Fusion Spike Revealed by Cryo-EMPreprint
Liu, C., Yang, Y., Gao, Y., Shen, C., Ju, B., Liu, C., Tang, X., Wei, J., Ma, X., Liu, W., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.02.972927 · Cited by 59
Self-citationZeng, Q., Li, Y., Huang, G., Wu, W., Dong, S.-Y., & Xu, Y. (2020) · medRxiv · doi:10.1101/2020.03.08.20031229 · Cited by 50
Bahl, K., Hübner, A., Davis, R. J., & Welsh, R. M. (2010) · Journal of Virology · doi:10.1128/jvi.02571-09 · Cited by 43
Li, T., Qiu, Z., Han, Y. C., et al. (2003) · PubMed · Cited by 43
Chen, Y., Shan, K.-J., & Qian, W. (2020) · Preprints.org · doi:10.20944/preprints202002.0258.v1 · Cited by 34
Self-citation
Cited by
Coronavirus envelope protein: current knowledge
Schoeman, D., & Fielding, B. C. (2019) · Virology Journal · doi:10.1186/s12985-019-1182-0 · Cited by 2,074
Therapeutic Targeting of the Tumor Microenvironment
Bejarano, L., Jordāo, M. J. C., & Joyce, J. A. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1808 · Cited by 1,653
Duan, L., Zheng, Q., Zhang, H., Niu, Y., Lou, Y., & Wang, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.576622 · Cited by 408
Wauters, E., Van Mol, P., Garg, A. D., Jansen, S., Van Herck, Y., Vanderbeke, L., Bassez, A., Boeckx, B., Malengier-Devlies, B., Timmerman, A., et al. (2021) · Cell Research · doi:10.1038/s41422-020-00455-9 · Cited by 345
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A
White, K. M., Rosales, R., Yildiz, S., Kehrer, T., Miorin, L., Moreno, E., Jangra, S., Uccellini, M. B., Rathnasinghe, R., Coughlan, L., et al. (2021) · Science · doi:10.1126/science.abf4058 · Cited by 343
Metadata
- Authors
- Liang, Y., Wang, M.-L., Chien, C.-S., Yarmishyn, A. A., Yang, Y.-P., Lai, W.-Y., Luo, Y.-H., Lin, Y.-T., Chen, Y.-J., Chang, P.-C., & Chiou, S.-H.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2020-05-12
- Volume
- 11
- Pages
- 1022-1022
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W3025292139
- Cited by
- 339
- References
- 116
- FWCI
- 7.94
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.